INNOCAN PHARMA Corp (INNPF)
InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to innovating drug delivery systems by integrating cannabidiol (CBD) with diverse pharmaceutical ingredients. Its operations extend across the United States, Poland, France, and other international markets. The company actively pursues research and development into CBD-loaded exosomes for treating conditions like COVID-19, as well as advancing CBD-infused liposomes. InnoCan Pharma also commercializes a range of branded CBD-integrated pharmaceutical and topical treatment products, such as CBD eye serum, face oil, face cream, facial serum, sleeping mask, recovery lotion, and the Relief & Go spray. Established in 2018, the corporation is headquartered in Calgary, Canada.
Sector: Pharmaceutical Preparations
Industry: Medical - Pharmaceuticals
InnoCan Pharma Corporation
OTC:INNPFHealthcare · Medical - Pharmaceuticals
-0.77%$1.29
Mkt Cap-
Float3.58M
O/S-
Inst Own-
SI<0.1%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$26.61M
Net Income-$1.12M
Total Assets$10.52M
Free Cash Flow$479K
Debt & Equity
Debt 14%
Equity 86%
Total Debt$930K
Total Equity$5.6M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
2-year cumulative
1:65
Nasdaq bars a compliance period at 1:250
- 1:65Reverse splitSep 5, 202565 shares → 1
Balance Sheet Details
Assets$10.52M
Liabilities$2.29M
Accounts Receivable$944K
Accounts Payable$235K
Inventory$2.18M
PP&E (Net)$86K
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Revenue | $26.61M | $29.44M | $13.66M | $2.56M | $196K | $8K | $0 | $0 |
| YoY Growth | -9.6% | 115.5% | 433.7% | 1205.6% | 2350.0% | - | - | - |
| Cost of Revenue | $2.68M | $3.25M | $1.68M | $452K | $75K | $5K | $24K | $0 |
| Gross Profit | $23.93M | $26.19M | $11.98M | $2.11M | $121K | $3K | -$24K | $0 |
| Gross Margin | 89.9% | 89.0% | 87.7% | 82.3% | 61.7% | 37.5% | - | - |
| Research and Development | $932K | $1.55M | $1.8M | $1.53M | $1.4M | $1.36M | $368K | $534K |
| Selling, General, and Administrative | $24.25M | $25.89M | $13.98M | $6.85M | $6.2M | $3.24M | $2.63M | $632K |
| Other | $0 | $0 | -$7.61M | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $25.19M | $27.43M | $8.18M | $8.37M | $7.6M | $4.73M | $3M | $1.17M |
| Operating Income (EBIT) | -$1.25M | -$1.25M | $3.8M | -$6.27M | -$7.48M | -$4.72M | -$3M | -$1.17M |
| Operating Margin | -4.7% | -4.2% | 27.8% | -244.9% | -3816.3% | -59062.5% | - | - |
| Interest Expense | $3K | $7K | $0 | $2K | $13K | $8K | $334K | $26K |
| Interest Income | $0 | $0 | $23K | $21K | $0 | $0 | $40K | $0 |
| Other Income (Expense) | $1.34M | $2.17M | -$7.84M | $2.38M | -$2.61M | -$5.23M | -$334K | $807K |
| Income Before Tax (EBT) | $85K | $919K | -$4.03M | -$3.89M | -$10.09M | -$9.95M | -$3.33M | -$1.19M |
| Income Tax Expense | $426K | $1.18M | $214K | $1K | $0 | $0 | $0 | -$161K |
| Net Income | -$1.12M | -$1.83M | -$4.7M | -$3.76M | -$10.05M | -$9.95M | -$3.33M | -$1.19M |
| Net Income Margin | -4.2% | -6.2% | -34.4% | -147.1% | -5126.0% | -124412.5% | - | - |
| Supplementary Data | ||||||||
| EPS | -0.25 | -0.42 | -1.19 | -0.98 | -2.91 | -3.99 | -1.51 | -0.54 |
| Diluted EPS | -0.25 | -0.42 | -1.19 | -0.98 | -2.91 | -3.99 | -1.51 | -0.54 |
| Weighted Average OS | 4.48M | 4.20M | 3.86M | 3.73M | 3.37M | 2.43M | 2.16M | 2.16M |
| EBITDA | $130K | -$1.21M | -$3.77M | -$3.7M | -$7.37M | -$4.93M | -$2.98M | $1.81M |
| EBITDA Margin | 0.5% | -4.1% | -27.6% | -144.5% | -3760.8% | -61682.6% | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Assets | ||||||||
| Current Assets | ||||||||
| Cash and Cash Equivalents | $6.69M | $5.01M | $3.88M | $4.95M | $11.05M | $2.34M | $1.97M | $214K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $6.69M | $5.01M | $3.88M | $4.95M | $11.05M | $2.34M | $1.97M | $214K |
| Accounts Receivable | $944K | $686K | $249K | $243K | $963K | $1.13M | $57K | $0 |
| Inventory | $2.18M | $3.32M | $1.74M | $1.13M | $510K | $430K | $31K | -$72K |
| Other Current Assets | $554K | $69K | $583K | $285K | $248K | $0 | $0 | $101K |
| Total Current Assets | $10.44M | $9.15M | $6.8M | $6.88M | $12.52M | $4.28M | $2.49M | $657K |
| Long-Term Assets | ||||||||
| Property, Plant & Equipment Net | $86K | $113K | $136K | $98K | $54K | $56K | $95K | $3K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $0 | $0 | -$98K | -$54K | -$56K | -$95K | $0 |
| Total Long-Term Assets | $86K | $113K | $136K | $98K | $54K | $56K | $95K | $3K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $10.52M | $9.26M | $6.94M | $6.98M | $12.57M | $4.33M | $2.58M | $660K |
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts Payable | $235K | $185K | $111K | $95K | $53K | $527K | $27K | $0 |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $318K | $432K | $384K | $409K | $0 |
| Other Current Liabilities | $386K | $1.56M | $1.95M | $304K | $3.08M | $6.99M | $661K | -$66K |
| Total Current Liabilities | $1.35M | $2.24M | $2.54M | $731K | $3.56M | $7.94M | $1.13M | $533K |
| Long-Term Liabilities | ||||||||
| Long-Term Debt | $930K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Liabilities | $930K | $0 | $11K | $20K | $0 | $1K | $38K | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $2.29M | $2.24M | $2.55M | $751K | $3.56M | $7.94M | $1.17M | $533K |
| Stockholders' Equity | ||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Retained Earnings | -$36.03M | -$34.91M | -$33.07M | -$28.37M | -$24.61M | -$14.56M | -$4.61M | -$1.27M |
| Comprehensive Income & Other | $0 | $0 | $0 | -$0 | $0 | $0 | $0 | $0 |
| Other Stockholders' Equity | $41.63M | $40.08M | $37.18M | $34.77M | $33.66M | $10.96M | $6.02M | $1.4M |
| Total Equity | $5.6M | $5.17M | $4.1M | $6.39M | $9.05M | -$3.61M | $1.41M | $127K |
| Minority Interest | $2.64M | $1.85M | $283K | -$169K | -$44K | $0 | $0 | $0 |
| Total Liabilities and Equity | $7.88M | $7.41M | $6.66M | $7.14M | $12.62M | $4.33M | $2.58M | $660K |
| Supplementary Data | ||||||||
| Total Debt | $930K | $10K | $33K | $34K | $1K | $38K | $72K | $0 |
| Net Debt | -$5.76M | -$5M | -$3.85M | -$4.91M | -$11.05M | -$2.3M | -$1.9M | -$214K |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Operating Activities | ||||||||
| Net Income | -$341K | -$262K | -$4.7M | -$3.89M | -$10.09M | -$9.95M | -$3.33M | -$1.19M |
| Depreciation & Amortization | $42K | $35K | $34K | $35K | $43K | $40K | $23K | $2M |
| Deferred Income Tax | $426K | $0 | $0 | -$2.77M | $2.31M | $5.25M | $294K | $0 |
| Stock-Based Compensation | $1.46M | $2.01M | $854K | $967K | $2.16M | $527K | $426K | $57K |
| Changes in Working Capital: | ||||||||
| Accounts Receivable | $0 | $17K | -$2K | -$15K | $2K | -$2K | -$63K | -$263K |
| Inventory | $1.14M | -$1.57M | -$616K | -$621K | -$79K | -$430K | $0 | $0 |
| Accounts Payable | $50K | $72K | $17K | $42K | -$474K | $500K | $27K | $0 |
| Other Working Capital | $384K | $278K | -$207K | $63K | -$418K | $406K | -$91K | $388K |
| Total Working Capital Change | $1.57M | -$1.2M | -$808K | -$531K | -$969K | $474K | -$127K | $125K |
| Other Non-Cash Items | -$2.67M | -$2.16M | $716K | $125K | -$83K | -$24K | $4K | -$1.9M |
| Net Cash from Operating | $495K | -$1.58M | -$3.9M | -$6.07M | -$6.63M | -$3.69M | -$2.71M | -$909K |
| Investing Activities | ||||||||
| Capital Expenditures | -$16K | -$15K | -$46K | -$26K | -$41K | $0 | -$9K | -$3K |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | -$7K | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $1K | $69K | -$38K | -$5K | -$62 | $0 | $0 | $0 |
| Net Cash from Investing | -$15K | $54K | -$84K | -$31K | -$48K | $0 | -$9K | -$3K |
| Financing Activities | ||||||||
| Debt Repaid | -$629K | $22K | $22K | $11K | $38K | $39K | $38K | - |
| Common Stock Issuance | $517K | $891K | $2.99M | $131K | $3.91M | $2.76M | $4.49M | $1.12M |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $1.83M | $2.94M | $136K | $11.43M | $1.3M | $0 | $1.92M |
| Net Cash from Financing | $1.15M | $2.7M | $2.92M | $125K | $15.3M | $4.02M | $4.45M | $1.12M |
| Forex Effect | $53K | -$56K | $9K | -$128K | $84K | $28K | $29K | $2K |
| Net Change in Cash | $1.68M | $1.12M | -$1.06M | -$6.1M | $8.71M | $365K | $1.76M | $208K |
| Supplementary Data | ||||||||
| Operating Cash Flow | $495K | -$1.58M | -$3.9M | -$6.07M | -$6.63M | -$3.69M | -$2.71M | -$909K |
| Capital Expenditure | -$16K | -$15K | -$46K | -$26K | -$41K | $0 | -$9K | -$3K |
| Free Cash Flow | $479K | -$1.59M | -$3.95M | -$6.09M | -$6.67M | -$3.69M | -$2.72M | -$912K |
| Cash at Beginning | $5.01M | $3.88M | $4.95M | $11.05M | $2.34M | $1.97M | $214K | $6K |
| Cash at End | $6.69M | $5.01M | $3.88M | $4.95M | $11.05M | $2.34M | $1.97M | $214K |